1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, India
2.1 Metabolic Disorders Market, India, Revenue ($m), 2024-2036
2.1.1 Cholesterol Tests Market, India, Revenue ($m), by Segment, 2024-2036
2.1.2 Diabetes Assays Market, India, Revenue ($m), by Segment, 2024-2036
2.2 Metabolic Disorders Market, India, Volume (Units), 2024-2036
2.2.1 Cholesterol Tests Market, India, Volume (Units), by Segment, 2024-2036
2.2.2 Diabetes Assays Market, India, Volume (Units), by Segment, 2024-2036
2.3 Metabolic Disorders Market, India, Average Price ($), 2024-2036
2.4 Metabolic Disorders Market, India, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market Pipeline Products
3.1 Metabolic Disorders Market Pipeline Products
3.2 Metabolic Disorders - Pipeline Products by Stage of Development
3.3 Metabolic Disorders - Pipeline Products by Segment
3.4 Metabolic Disorders - Pipeline Products by Territory
3.5 Metabolic Disorders - Pipeline Products by Regulatory Path
3.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in India, Metabolic Disorders Market
4.1 Roche Diagnostics International Ltd
4.1.1 Company Overview
4.2 Siemens Healthineers AG
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Beckman Coulter Inc
4.4.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
5.2 Other Significant Developments
5.2.1 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
5.3 Product News
5.3.1 Mar 11, 2026: PatentVest Announces Intellectual Property Collaboration With Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
5.3.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
5.3.3 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
5.3.4 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
5.4 Strategy And Business Planning
5.4.1 Mar 11, 2026: PatentVest Announces Intellectual Property Collaboration With Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
5.4.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Table 2: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 3: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Table 4: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Table 5: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Table 6: Diabetes Assays Market, India, Volume (Units), 2024-2036
Table 7: Metabolic Disorders Market, India, Average Price ($), 2024-2036
Table 8: Metabolic Disorders Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Metabolic Disorders - Pipeline Products by Stage of Development
Table 11: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 12: Metabolic Disorders - Pipeline Products by Segment
Table 13: Metabolic Disorders - Pipeline Products by Territory
Table 14: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 15: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cholesterol Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 3: Diabetes Assays Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 4: Metabolic Disorders Market, India, Volume (Units), 2024-2036
Figure 5: Cholesterol Tests Market, India, Volume (Units), 2024-2036
Figure 6: Diabetes Assays Market, India, Volume (Units), 2024-2036
Figure 7: Metabolic Disorders Market, India, Company Share (%), 2025
Figure 8: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 9: Metabolic Disorders - Pipeline Products by Segment
Figure 10: Metabolic Disorders - Pipeline Products by Territory
Figure 11: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 12: Metabolic Disorders - Pipeline Products by Estimated Approval Date